PubRank

Anne Schuchat

Author PubWeight™ 146.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003 15.48
2 Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006 7.68
3 Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002 6.51
4 Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008 6.13
5 Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006 5.56
6 Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002 5.23
7 A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002 4.88
8 Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002 4.08
9 Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis 2011 3.46
10 An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med 2003 3.32
11 Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011 2.99
12 Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis 2002 2.76
13 Seasonal patterns of invasive pneumococcal disease. Emerg Infect Dis 2003 2.29
14 Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009 2.25
15 Superspreading SARS events, Beijing, 2003. Emerg Infect Dis 2004 2.03
16 Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg Infect Dis 2002 2.03
17 Increased prevalence of pediatric pneumococcal serotypes in elderly adults. Clin Infect Dis 2005 2.03
18 First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep 2014 2.00
19 Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet 2009 1.95
20 Perinatal infections due to group B streptococci. Obstet Gynecol 2004 1.69
21 Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis 2005 1.68
22 Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med 2006 1.67
23 Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001. Emerg Infect Dis 2002 1.59
24 Disease surveillance and the academic, clinical, and public health communities. Emerg Infect Dis 2003 1.58
25 Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity. Vaccine 2005 1.57
26 Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis 2004 1.57
27 Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response. Emerg Infect Dis 2002 1.53
28 Population-based surveillance for postpartum invasive group a streptococcus infections, 1995-2000. Clin Infect Dis 2002 1.53
29 Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children. Pediatr Infect Dis J 2008 1.50
30 Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003 1.49
31 Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis 2003 1.48
32 Risk factors for SARS among persons without known contact with SARS patients, Beijing, China. Emerg Infect Dis 2004 1.48
33 Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics 2002 1.47
34 Benefits from immunization during the vaccines for children program era - United States, 1994-2013. MMWR Morb Mortal Wkly Rep 2014 1.44
35 Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. J Infect Dis 2004 1.43
36 Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics 2006 1.41
37 Severe acute respiratory syndrome, Beijing, 2003. Emerg Infect Dis 2004 1.37
38 Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health 2010 1.33
39 Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization. AIDS 2010 1.32
40 Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use. Pediatrics 2010 1.26
41 Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet 2005 1.23
42 Vaccination and perinatal infection prevention practices among obstetrician-gynecologists. Obstet Gynecol 2003 1.19
43 The use of chlorhexidine to reduce maternal and neonatal mortality and morbidity in low-resource settings. Int J Gynaecol Obstet 2007 1.17
44 Perinatal group B streptococcal disease. Best Pract Res Clin Obstet Gynaecol 2007 1.17
45 Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique. Trop Med Int Health 2006 1.15
46 Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia. Vaccine 2008 1.15
47 Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 2005 1.15
48 Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol 2003 1.14
49 Severe pneumonia in Mozambican young children: clinical and radiological characteristics and risk factors. J Trop Pediatr 2009 1.13
50 Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults. J Infect Dis 2003 1.13
51 Trends in sepsis-related neonatal mortality in the United States, 1985-1998. Pediatr Infect Dis J 2004 1.11
52 Vaccine-preventable diseases, immunizations, and MMWR--1961-2011. MMWR Surveill Summ 2011 1.10
53 Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly. Vaccine 2002 1.09
54 Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998--2003. Vaccine 2008 1.03
55 Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults. J Infect Dis 2003 1.00
56 Risk factors for invasive pneumococcal disease among Navajo adults. Am J Epidemiol 2007 0.92
57 Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community. Clin Infect Dis 2002 0.89
58 Sentinel surveillance: a reliable way to track antibiotic resistance in communities? Emerg Infect Dis 2002 0.88
59 Streptococcus pneumoniae and Haemophilus influenzae type B Carriage, Central Asia. Emerg Infect Dis 2005 0.88
60 Impact of intrapartum antibiotics on the care and evaluation of the neonate. Pediatr Infect Dis J 2003 0.87
61 Vaccine-preventable diseases, immunizations, and the Epidemic Intelligence Service. Am J Epidemiol 2011 0.87
62 Public health issues related to infection in pregnancy and cerebral palsy. Ment Retard Dev Disabil Res Rev 2002 0.87
63 Invasive group-A streptococcal infection in an allograft recipient. A case report. J Bone Joint Surg Am 2007 0.86
64 Infections in international pregnancy study: performance of the optical immunoassay test for detection of group B streptococcus. J Clin Microbiol 2003 0.85
65 Easing the burden: characterizing the disease burden of neonatal group B streptococcal disease to motivate prevention. Clin Infect Dis 2004 0.85
66 Cultivation of an Adaptive Domestic Network for Surveillance and Evaluation of Emerging Infections. Emerg Infect Dis 2015 0.83
67 Adults with invasive pneumococcal disease: missed opportunities for vaccination. Am J Prev Med 2006 0.80
68 Implementing an Ebola Vaccine Study - Sierra Leone. MMWR Suppl 2016 0.79
69 From pandemic suspect to the postvaccine era: the Haemophilus influenzae story. Clin Infect Dis 2007 0.78
70 Delivering pneumococcal vaccine to a high risk population: the Navajo experience. Hum Vaccin 2005 0.78
71 Barriers to implementing the group B streptococcal prevention guidelines. Birth 2002 0.77
72 Prevention of neonatal sepsis. Clin Perinatol 2005 0.77
73 Progress towards demonstrating the impact of Haemophilus influenzae type b conjugate vaccines globally. J Pediatr 2013 0.77
74 1918 and 2009: a tale of two pandemics. Public Health Rep 2010 0.76
75 Report from the CDC. Awareness of perinatal group B streptococcal infection among women of childbearing age in the United States, 1999 and 2002. J Womens Health (Larchmt) 2003 0.76
76 A human papillomavirus type 16 vaccine. N Engl J Med 2003 0.75
77 Protecting adults from influenza: tis the season to learn from the pandemic. J Infect Dis 2012 0.75
78 Perinatal group B streptococcal disease prevention, Minnesota. Emerg Infect Dis 2005 0.75
79 Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era. Microbiol Spectr 2016 0.75
80 Global health and the US Centers for Disease Control and Prevention. Lancet 2014 0.75
81 Preventing complications from 2009 influenza A (H1N1) in persons with underlying lung diseases: a formidable challenge for 2010 Year of the Lung. Int J Tuberc Lung Dis 2010 0.75
82 Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes. Infect Dis Obstet Gynecol 2005 0.75